Howard Scher

14PUBLICATIONS

198CO-AUTHORS

Molecular targetsRadiation therapyNatural language processingCancer therapy (excl. chemotherapy and radiation therapy)Clinical chemistry (incl. diagnostics)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (14)

Sort by Publication Date:

|Jul 09, 2026

Neoadjuvant intraprostatic immunotherapy for high-risk localized prostate cancer.

|Jun 15, 2026

Reprogramming of TLR-Ferroptosis Signaling and Immunometabolic Pathways Overcomes Myeloid Suppression to Improve Checkpoint Blockade in Prostate Cancer.

|Feb 19, 2026

Apalutamide + Abiraterone Acetate plus Prednisone + Leuprolide with Stereotactic, Ultra-Hypofractionated Radiation in Very High-Risk Prostate Cancer: A Single-Arm, Phase 2 Study.

Sean M McBride, Daniel E Spratt, Marisa Kollmeier

|Nov 20, 2025

Accelerating Drug Development in Hormone-Naïve Prostate Cancer through Multimodal Therapy Strategies: The MetaCURE Phase 2 Randomized Clinical Trial.

Deaglan McHugh, Matthew Dallos, Min Yuen Teo

|Nov 07, 2024

Automated real-world data integration improves cancer outcome prediction.

Justin Jee, Christopher Fong, Karl Pichotta

|Oct 01, 2024

Two decades of advances in clinical oncology - lessons learned and future directions.

Susana Banerjee, Christopher M Booth, Eduardo Bruera

Pageof 3

Frequent Collaborators

Michael Morris

Dana Rathkopf

Jeremie Calais

Karen A Autio

Michael F Berger

Wassim Abida

Emmanuel S Antonarakis

2 joint publications

Himisha Beltran

2 joint publications

Susan F Slovin

2 joint publications

Ana M Aparicio

Frequent Collaborators

Michael Morris

Dana Rathkopf

Jeremie Calais

Karen A Autio